Net 1 UEPS Technologies, Inc. (UEPS) Reaches $9.46 After 3.00% Down Move; Shorts at VECTURA GROUP PLC (VEGPF) Lowered By 1.08%

February 15, 2018 - By Jonathan Benavides

VECTURA GROUP PLC (OTCMKTS:VEGPF) had a decrease of 1.08% in short interest. VEGPF’s SI was 484,700 shares in February as released by FINRA. Its down 1.08% from 490,000 shares previously. With 25,700 avg volume, 19 days are for VECTURA GROUP PLC (OTCMKTS:VEGPF)’s short sellers to cover VEGPF’s short positions. It closed at $1.05 lastly. It is down 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.

The stock of Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS) is a huge mover today! The stock decreased 3.47% or $0.34 during the last trading session, reaching $9.46. About 202,641 shares traded. Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS) has declined 7.12% since February 15, 2017 and is downtrending. It has underperformed by 23.82% the S&P500.The move comes after 9 months negative chart setup for the $537.63M company. It was reported on Feb, 15 by Barchart.com. We have $9.18 PT which if reached, will make NASDAQ:UEPS worth $16.13 million less.

Vectura Group plc researches, develops, and commercializes novel therapeutic products and drug delivery systems for the treatment of airways-related diseases. The company has market cap of $619.44 million. The companyÂ’s marketed products include Ultibro Breezhaler and Seebri Breezhaler for the treatment of chronic obstructive pulmonary disease ; AirFlusal Forspiro for the treatment of asthma and COPD; ADVATE for the treatment of haemophilia A; and Adept for the treatment of surgical adhesions. It currently has negative earnings. The Company’s generic products include VR315, VR506, and VR632 for the treatment of asthma; and Phase III clinical stage products include VR475 for the treatment of severe adult asthma, and VR876 for the treatment of lung diseases, as well as NVA237 and QVA149 for the treatment of COPD for which filed NDA to the Food and Drug Administration.

Investors sentiment decreased to 1.22 in Q3 2017. Its down 0.07, from 1.29 in 2017Q2. It is negative, as 7 investors sold Net 1 UEPS Technologies, Inc. shares while 25 reduced holdings. 15 funds opened positions while 24 raised stakes. 22.00 million shares or 3.78% less from 22.87 million shares in 2017Q2 were reported. Credit Suisse Ag has 29,213 shares. Wells Fargo Mn holds 16,560 shares. Macquarie Gp Incorporated Limited reported 0% of its portfolio in Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS). Smith Asset Grp L P owns 20,058 shares or 0.01% of their US portfolio. Boston stated it has 0% in Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS). Acadian Asset Mgmt Ltd Company accumulated 878,776 shares. 114,800 were accumulated by Wedge Capital Mngmt L Lp Nc. Seizert Capital Ltd Liability Company holds 0.19% or 525,650 shares. Peak6 Invs L P holds 0% or 16,132 shares in its portfolio. Massachusetts-based Geode Capital Limited Liability Corporation has invested 0% in Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS). Vanguard Inc invested 0% of its portfolio in Net 1 UEPS Technologies, Inc. (NASDAQ:UEPS). Gargoyle Inv Advisor Ltd Limited Liability Company invested in 0.1% or 28,852 shares. Aperio Ltd owns 36,612 shares for 0% of their portfolio. Virginia Retirement Systems Et Al reported 115,700 shares stake. Brandes Investment Partners Ltd Partnership reported 0% stake.

Net 1 UEPS Technologies, Inc. provides payment solutions, transaction processing services, and financial technologies to various industries in South Africa, South Korea, and internationally. The company has market cap of $537.63 million. The firm develops and markets transaction processing solutions that comprise its smart card alternative payment system for the unbanked and under-banked populations of developing economies, and for mobile transaction channels. It has a 9.12 P/E ratio. It operates through three divisions: South African Transaction Processing, International Transaction Processing, and Financial Inclusion and Applied Technologies.

Since September 20, 2017, it had 0 insider buys, and 4 sales for $465,864 activity. The insider Edwards Paul sold $50,900. Seabrooke Christopher Stefan sold 24,533 shares worth $241,159. On Tuesday, December 12 the insider Pein Alasdair Jonathan Kemsley sold $71,565.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>